Company: Pandion Therapeutics
Job title: Co-Founder, President & CSO
Dr. Jo Viney is an entrepreneurial scientist and experienced biotech executive. A self-described “drug-hunter”, she has successfully advanced a number of programs into the clinic.
Jo is Co-Founder, President and CSO of Pandion Therapeutics, a startup company in Cambridge, MA focused on developing new therapies for treating autoimmune and inflammatory diseases (www.pandiontx.com). Prior to Pandion, she worked at Immunex, Amgen, and most recently Biogen where she was Senior Vice President of the Drug Discovery organization.
Throughout her career, Jo has been passionate about workplace inclusiveness. Since 2015 she has served on the Board of WEST – a non-profit organization supporting early to mid-career women (www.westorg.org). She was WEST’s President for the 2017-2018 term.
Jo has maintained longstanding membership with the Society for Mucosal Immunology (SMI) and American Society of Immunologists (AAI). She has served numerous terms on the SMI Board, was President from 2011-2013, and together with SMI colleagues and Nature Publishing Group, she launched the journal Mucosal Immunology.
Jo is a member of the Board of Directors for Quench Bio, Finch Therapeutics, and Carogen Corp. She also serves on the Scientific Advisory Board for HotSpot Therapeutics and Vaxart Inc.
Regulation of Treg Expansion by the IL-2 Mutein, PT101 10:00 am
Discussing the importance of Treg selectivity Exploring dosing strategies Translation of model systems to human studiesRead more
day: Day One